Citius Pharmaceuticals Inc vs PayPal Holdings, Inc. — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while PayPal Holdings, Inc. trades at $58.29 (market cap $50.47B). The key difference: PayPal Holdings, Inc. is far larger — about 2522.2× Citius Pharmaceuticals Inc's market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | PYPL | |
|---|---|---|
Market Cap | $20.01M | $50.47B |
Sector | Health | Financials |
52-Week High | $1.82 | $76.13 |
52-Week Low | $0.48 | $39.08 |
Enterprise Value | $16.23M | $52.62B |
Dividend Yield | — | 0.95% |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →